Sign in to view content

Port Delivery System with Ranibizumab PDS for Continuous Treatment in DME and DR Additional Results from the Phase 3 Pagoda and Pavilion Trials

Dennis M. Marcus, MD

Video
Published 2023

Related

Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023
Quality of Life and Retinal Disease During the COVID-19 Pandemic
Peter Y Zhao, MD
Annual Meeting Talks
2021
Safety and Efficacy of CRISPR-Based Genome Editing for Neovascular AMD
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more